BB: What is considered the intermediate duration? CH: In broad terms, five to seven years on average offers an attractive balance of risk and reward in our view. Cooper Howard, director and fixed ...

Adding dapagliflozin to standard heart failure therapies provides “intermediate value” for American patients who have heart failure with reduced ejection fraction (HFrEF), a new cost-effectiveness ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...